Trial Profile
Xyrem for Treatment Refractory Insomnia Due to PTSD
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 21 Nov 2006 The expected completion date for this trial is now 1 Sep 2007.
- 20 Oct 2006 New trial record.